Small Pharma Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$23.8M
- Investors
-
1
Small Pharma General Information
Description
Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small Pharma is developing N,N-dimethyltryptamine and a pipeline of novel patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders. It has one operating segment, research and development ("R&D") of psychedelic and nonpsychedelic medicine.
Contact Information
Website
www.smallpharma.comCorporate Office
- 50 Featherstone Street
- London EC1Y 8RT
- England, United Kingdom
Corporate Office
- 50 Featherstone Street
- London EC1Y 8RT
- England, United Kingdom
Small Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 23-Oct-2023 | $23.8M | Completed | Generating Revenue | ||
| 7. PIPE | 29-Apr-2021 | Completed | Clinical Trials - Phase 2 | |||
| 6. Reverse Merger | 29-Apr-2021 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC | 27-Jun-2020 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC | 07-Apr-2017 | Completed | Startup | |||
| 3. Grant | 01-Jan-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2016 | $125K | Completed | Startup | ||
| 1. Early Stage VC | 18-Aug-2015 | $125K | $125K | Completed | Startup |
Small Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Small Pharma Comparisons
Industry
Financing
Details
Small Pharma Competitors (25)
One of Small Pharma’s 25 competitors is Gesynta Pharma, a Venture Capital-Backed company based in Stockholm, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Supernus | Formerly VC-backed | Rockville, MD | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Sumitomo Pharma (Pharmaceuticals) | Corporation | Mississauga, Canada | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Small Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Small Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Small Pharma Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACF Investors | Venture Capital | Minority | ||
| Acreditus Partners | Angel Group | Minority | ||
| Ambria Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Small Pharma Acquisitions (1)
Small Pharma’s most recent deal was a Merger/Acquisition with Unilock Capital. The deal was made on 29-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Unilock Capital | 29-Apr-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Small Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Retailers
Industry
Rank
Percentile
Drug Retail
Subindustry
Rank
Percentile
Small Pharma FAQs
-
When was Small Pharma founded?
Small Pharma was founded in 2015.
-
Where is Small Pharma headquartered?
Small Pharma is headquartered in London, United Kingdom.
-
What is the size of Small Pharma?
Small Pharma has 23 total employees.
-
What industry is Small Pharma in?
Small Pharma’s primary industry is Drug Discovery.
-
Is Small Pharma a private or public company?
Small Pharma is a Private company.
-
What is the current valuation of Small Pharma?
The current valuation of Small Pharma is .
-
What is Small Pharma’s current revenue?
The current revenue for Small Pharma is .
-
How much funding has Small Pharma raised over time?
Small Pharma has raised $48.5M.
-
Who are Small Pharma’s investors?
ACF Investors, Acreditus Partners, Ambria Capital, , and are 5 of 16 investors who have invested in Small Pharma.
-
Who are Small Pharma’s competitors?
Gesynta Pharma, Supernus, Gilead, Sumitomo Pharma (Pharmaceuticals), and Merck & Co. are some of the 25 competitors of Small Pharma.
-
When was Small Pharma acquired?
Small Pharma was acquired on 23-Oct-2023.
-
Who acquired Small Pharma?
Small Pharma was acquired by Cybin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
